Review
Published on 17 Dec 2021
Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.789982
- 25,565 views
- 17 citations
Type at least 3 characters
551 articles
Case Report
Published on 16 Dec 2021
Cariprazine Use in Early Psychosis: Three Case Reports
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.788281
- 4,085 views
- 4 citations
Original Research
Published on 16 Dec 2021
The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.784366
- 4,138 views
- 4 citations
Perspective
Published on 16 Dec 2021
Partial Agonists and Dual Disorders: Focus on Dual Schizophrenia
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.769623
- 5,510 views
- 11 citations
Original Research
Published on 15 Dec 2021
Cang-Ai Volatile Oil Ameliorates Depressive Behavior Induced by Chronic Stress Through IDO-Mediated Tryptophan Degradation Pathway
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.791991
- 4,730 views
- 16 citations
Mini Review
Published on 14 Dec 2021
Reducing Addiction in Bipolar Disorder via Hacking the Dopaminergic System
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.803208
- 13,679 views
- 12 citations
Review
Published on 14 Dec 2021
Cariprazine in the Treatment of Bipolar Disorder: Within and Beyond Clinical Trials
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.769897
- 20,890 views
- 13 citations
Review
Published on 13 Dec 2021
1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.742856
- 7,531 views
- 4 citations
Mini Review
Published on 07 Dec 2021
Which Emergent Medication Should I Give Next? Repeated Use of Emergent Medications to Treat Acute Agitation
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.750686
- 10,520 views
- 1 citation
Original Research
Published on 06 Dec 2021
Occurrence of Side Effects in Treatment-Resistant Depression: Role of Clinical, Socio-Demographic and Environmental Characteristics
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.795666
- 3,747 views
- 7 citations
Original Research
Published on 03 Dec 2021
Clinical Investigation on the Impact of Cannabis Abuse on Thyroid Hormones and Associated Psychiatric Manifestations in the Male Population
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.730388
- 43,440 views
- 4 citations
Original Research
Published on 03 Dec 2021
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.780975
- 2,323 views
- 8 citations
Original Research
Published on 29 Nov 2021
Nx4 Reduced Susceptibility to Distraction in an Attention Modulation Task
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.746215
- 4,933 views
- 9 citations
Methods
Published on 24 Nov 2021
Therapeutic Reference Ranges for Psychotropic Drugs: A Protocol for Systematic Reviews
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.787043
- 5,738 views
- 22 citations
Hypothesis and Theory
Published on 24 Nov 2021
An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.710338
- 22,564 views
- 29 citations
Original Research
Published on 24 Nov 2021
The More, the Merrier…? Antipsychotic Polypharmacy Treatment Strategies in Schizophrenia From a Pharmacology Perspective
in Psychopharmacology
Frontiers in Psychiatry
doi 10.3389/fpsyt.2021.760181
- 11,870 views
- 18 citations